Beta-ketoimine Ligand Metal Complex for MOCVD Precursor
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current metal organic chemical vapor deposition (MOCVD) processes face challenges in developing precursors with high volatility, low melting points, and excellent thermal stability for fabricating high-quality thin films, as existing precursors often have high melting points and thermal instability.
Innovation Solution
A β-ketoimine ligand is synthesized and used to form a metal complex compound with strontium, which exhibits low melting points, excellent thermal stability, and good solubility in organic solvents, suitable for MOCVD processes, by reacting hydroxypivalic acid ester with an alkylating agent, then with a ketone compound, and finally with 1-dimethylamino-2-propylamine to create a volatile and thermally stable metal precursor.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing precursors are used in MOCVD processes, then the fabrication process can be performed, but the precursors exhibit high melting points and thermal instability
Solution Approach 1:
The patent changes the chemical parameters of the precursor by developing a novel β-ketoimine ligand structure with specific alkyl group substitutions. This molecular design modification alters the physical and chemical properties of the metal complex, resulting in lower melting points and enhanced thermal stability compared to conventional precursors. The parameter change is achieved through systematic variation of the ligand structure rather than changing the fundamental precursor type.
Solution Approach 2:
The patent creates a composite molecular structure by combining the β-ketoimine ligand framework with specific alkyl groups (methyl, ethyl, isopropyl, etc.) to form a new class of metal complex compounds. This composite approach allows optimization of multiple properties simultaneously - the core ligand provides thermal stability while the alkyl substituents reduce melting point and enhance volatility, resolving the contradiction between these properties.
2Productivity
If precursors with high volatility are developed, then film formation rate improves, but thermal stability may deteriorate
Solution Approach 1:
The patent optimizes the volatility parameter by introducing specific alkyl groups of controlled size and branching at predetermined positions on the β-ketoimine ligand. This parameter change increases vapor pressure and film formation rate while the core ligand structure maintains thermal stability. The key is changing molecular weight and shape parameters rather than the fundamental chemical composition.
Solution Approach 2:
The patent applies local quality by placing specific functional groups (alkyl substituents) at particular positions on the ligand molecule. The core β-ketoimine structure provides thermal stability locally, while the alkyl groups at specific positions provide volatility enhancement. This spatial differentiation of functions allows simultaneous achievement of high film formation rate and thermal stability.
3Ease of operation
If the melting point of precursors is reduced for better processability, then handling and deposition improve, but thermal stability may worsen
Solution Approach 1:
The patent changes physical parameters (melting point, viscosity) by modifying molecular structure through alkyl substitution while maintaining or enhancing thermal stability. The parameter change is achieved by controlling molecular weight, symmetry, and intermolecular interactions through strategic placement of alkyl groups, decoupling melting point from thermal stability.
Solution Approach 2:
The patent segments the precursor molecule into functionally distinct regions: the β-ketoimine core provides thermal stability, while the alkyl substituents control melting point and solubility. This segmentation allows independent optimization of each property by modifying the appropriate molecular segment without affecting the other critical properties.
4Manufacturing precision
If precursors with excellent solubility in organic solvents are designed, then uniform thin film fabrication improves, but molecular structure complexity increases
Solution Approach 1:
The patent enhances solubility through local modification of the ligand structure by introducing alkyl groups at specific positions. These localized changes improve interaction with organic solvents and promote uniform film formation without requiring complex overall molecular architecture. The core structure remains relatively simple, with solubility optimized through targeted local modifications.
Solution Approach 2:
The patent changes solubility parameters by modifying the ligand's hydrophobicity through alkyl substitution. This parameter change improves compatibility with organic solvents and enables uniform thin film fabrication. The complexity increase is minimal, involving only substitution of hydrogen atoms with alkyl groups rather than fundamental structural redesign.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The β-ketoimine ligand-based metal complex compound demonstrates improved volatility, thermal stability, and solubility, enabling the formation of high-quality thin films with enhanced film formation rates and reduced risk of precipitation and quality deterioration during chemical vapor deposition.
Implementation Method 1
a method for forming a metal thin film on a workpiece, the method including vaporizing a metal precursor including the metal complex compound, and supplying the vaporized metal precursor to form a metal thin film on the workpiece
Data Source
AI summary
The β-ketoimine ligand is represented by the following formula 1:wherein R1 and R2 are each independently a C1-C5 alkyl group. A metal complex compound includes the β-ketoimine ligand. A method of forming the β-ketoimine ligand and a method of forming a thin film using the metal complex compound including β-ketoimine ligand are provided.